Phillip J. Koo, MD, presented “Differentiating PSMA Diagnostics & Therapeutics” during the 24th Future Directions in Urology Symposium in August 2024 in Colorado Springs, Colorado.
How to cite: Koo, Phillip J. “Differentiating PSMA Diagnostics & Therapeutics.” August 2024. Accessed Nov 2024. https://grandroundsinurology.com/differentiating-psma-diagnostics-therapeutics/
Differentiating PSMA Diagnostics & Therapeutics – Summary
Phillip J. Koo, MD, examines radiopharmaceuticals, addressing trends and challenges in imaging and therapeutics. In this 11-minute presentation, Dr. Koo theorizes that radiology’s commoditization, accelerated by private equity and shifting toward high-volume, low-quality imaging, has raised concerns about diagnostic consistency.
Dr. Koo shares that the accessibility of PSMA PET imaging has rapidly expanded in the US. High utilization rates have led to issues of potential overuse and over-treatment, underscoring the need for more deliberate clinical decision-making. Variable imaging quality, often tied to the facility’s focus on throughput over accuracy, presents risks in diagnostics and patient outcomes. His presentation calls for ongoing advancements in both technology and professional collaboration to fully realize these tools’ therapeutic and diagnostic value.
The Future Directions in Urology Symposium (FDUS) is an annual urology think tank and non-CME educational summit that brings together industry figures and experts to discuss the current state of genitourinary care and define future directions in treatment. Dr. Dreicer delivered this educational activity during the 24th iteration of the meeting in August 2024 in Colorado Springs, Colorado.
ABOUT THE AUTHOR
Phillip J. Koo, MD, is the Chief of Diagnostic Imaging at the Banner MD Anderson Cancer Center in Phoenix, Arizona. Prior to this, he was Chief of Nuclear Medicine and Associate Professor of Radiology at the University of Colorado School of Medicine in Aurora, Colorado. He completed his fellowship at the Harvard Medical School Joint Program in Nuclear Medicine in Boston, Massachusetts. Dr. Koo is a diplomate of both the American Board of Radiology (ABR) and American Board of Nuclear Medicine(ABNM).
